$VERB
Verb Technology Company, Inc. Stock $verb

$verb Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000149315222032056 Filed on November 14, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$2.158M	$2.187M	$2.900M
YoY Change	-20.25%	-24.59%	1.4%
Cost Of Revenue	$767.0K	$736.0K	$1.086M
YoY Change	-29.24%	-32.23%	-17.1%
Gross Profit	$1.391M	$1.451M	$1.814M
YoY Change	-14.24%	-20.01%	16.28%
Gross Profit Margin	64.46%	66.35%	62.55%
Selling, General & Admin	$4.671M	$6.965M	$6.130M
YoY Change	-17.94%	13.62%	-7.96%
% of Gross Profit	335.8%	480.01%	337.93%
Research & Development	$854.0K	$1.372M	$3.513M
YoY Change	-68.78%	-60.95%	45.77%
% of Gross Profit	61.39%	94.56%	193.66%
Depreciation & Amortization	$1.085M	$840.0K	$401.0K
YoY Change	134.34%	109.48%	2.82%
% of Gross Profit	78.0%	57.89%	22.11%
Operating Expenses	$6.460M	$9.127M	$10.04M
YoY Change	-27.33%	-9.12%	6.28%
Operating Profit	-$5.069M	-$7.676M	-$8.229M
YoY Change	-30.26%	-6.72%	4.3%
Interest Expense	-$426.0K	$550.0K	-$666.0K
YoY Change	-124.51%	-182.58%	-214.83%
% of Operating Profit
Other Income/Expense, Net	$1.414M	-$352.0K	$8.000K
YoY Change	20100.0%	-4500.0%
Pretax Income	-$16.05M	-$8.028M	-$8.805M
YoY Change	190.53%	-8.82%	20.29%
Income Tax
% Of Pretax Income
Net Earnings	-$16.29M	-$8.028M	-$8.805M
YoY Change	194.93%	-8.82%	20.29%
Net Earnings / Revenue	-754.96%	-367.08%	-303.62%
Basic Earnings Per Share		-$0.08	-$0.14
Diluted Earnings Per Share	-$0.15	-$78.62K	-$131.9K
COMMON SHARES
Basic Shares Outstanding	116.2M shares	102.4M shares	66.76M shares
Diluted Shares Outstanding		2.553M shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.429M	$921.0K	$3.658M
YoY Change	159.23%	-74.82%	-65.88%
Cash & Equivalents	$2.429M	$921.0K	$3.658M
Short-Term Investments
Other Short-Term Assets	$605.0K	$738.0K	$905.0K
YoY Change	-28.57%	-18.45%	33.09%
Inventory			$5.000K
Prepaid Expenses	$605.0K	$738.0K
Receivables	$1.024M	$1.438M	$1.488M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$4.058M	$3.097M	$6.056M
YoY Change	27.05%	-48.86%	-52.54%
LONG-TERM ASSETS
Property, Plant & Equipment	$537.0K	$582.0K	$5.383M
YoY Change	-23.5%	-89.19%	42.41%
Goodwill	$9.581M	$19.76M
YoY Change	-51.52%
Intangibles	$833.0K	$2.966M
YoY Change	-78.93%
Long-Term Investments
YoY Change
Other Assets	$306.0K	$306.0K	$317.0K
YoY Change	4.44%	-3.47%	352.86%
Total Long-Term Assets	$20.43M	$31.69M	$29.83M
YoY Change	-34.58%	6.21%	0.04%
TOTAL ASSETS
Total Short-Term Assets	$4.058M	$3.097M	$6.056M
Total Long-Term Assets	$20.43M	$31.69M	$29.83M
Total Assets	$24.49M	$34.78M	$35.89M
YoY Change	-28.87%	-3.08%	-15.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.638M	$3.833M	$7.282M
YoY Change	23.65%	-47.36%	36.11%
Accrued Expenses	$1.646M	$3.851M	$2.224M
YoY Change	-71.73%	73.16%	56.62%
Deferred Revenue	$1.340M	$1.549M
YoY Change	35.9%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$5.803M	$4.171M	$40.00K
YoY Change	14407.5%	10327.5%	-98.69%
Total Short-Term Liabilities	$16.53M	$16.40M	$18.14M
YoY Change	-7.83%	-9.61%	17.26%
LONG-TERM LIABILITIES
Long-Term Debt	$1.215M	$150.0K	$875.0K
YoY Change	38.86%	-82.86%	-40.07%
Other Long-Term Liabilities	$1.581M	$1.705M	$2.464M
YoY Change	-31.23%	-30.8%	-31.93%
Total Long-Term Liabilities	$2.796M	$1.855M	$3.339M
YoY Change	-11.91%	-44.44%	-34.27%
TOTAL LIABILITIES
Total Short-Term Liabilities	$16.53M	$16.40M	$18.14M
Total Long-Term Liabilities	$2.796M	$1.855M	$3.339M
Total Liabilities	$19.33M	$18.25M	$21.48M
YoY Change	-8.45%	-15.03%	3.26%
SHAREHOLDERS EQUITY
Retained Earnings	-$153.5M	-$137.4M
YoY Change	32.27%
Common Stock	$12.00K	$10.00K
YoY Change	71.43%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$5.166M	$16.53M	$14.41M
YoY Change
Total Liabilities & Shareholders Equity	$24.49M	$34.78M	$35.89M
YoY Change	-28.87%	-3.08%	-15.71%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	-$16.29M	-$8.028M	-$8.805M
YoY Change	194.93%	-8.82%	20.29%
Depreciation, Depletion And Amortization	$1.085M	$840.0K	$401.0K
YoY Change	134.34%	109.48%	2.82%
Cash From Operating Activities	-$3.431M	-$4.973M	-$4.603M
YoY Change	-55.09%	8.04%	-10.1%
INVESTING ACTIVITIES
Capital Expenditures	$346.0K	-$191.0K	-$2.355M
YoY Change	327.16%	-91.89%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change			-100.0%
Cash From Investing Activities	-$346.0K	-$191.0K	-$2.355M
YoY Change	-527.16%	-91.89%	-1123.91%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$6.595M
YoY Change			-54.55%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	5.285M	538.0K	4.167M
YoY Change	9.26%	-87.09%	-70.74%
NET CHANGE
Cash From Operating Activities	-3.431M	-4.973M	-4.603M
Cash From Investing Activities	-346.0K	-191.0K	-2.355M
Cash From Financing Activities	5.285M	538.0K	4.167M
Net Change In Cash	1.508M	-4.626M	-2.791M
YoY Change	-155.42%	65.75%	-129.85%
FREE CASH FLOW
Cash From Operating Activities	-$3.431M	-$4.973M	-$4.603M
Capital Expenditures	$346.0K	-$191.0K	-$2.355M
Free Cash Flow	-$3.777M	-$4.782M	-$2.248M
YoY Change	-51.08%	112.72%	-56.09%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q3	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001566610
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022Q3	us-gaap	Redeemable Preferred Stock Dividends RedeemablePreferredStockDividends		usd
	us-gaap	Redeemable Preferred Stock Dividends RedeemablePreferredStockDividends		usd
	VERB	Stock Issued During Period Value Commitment Fee Related To Equity Line Of Credit Agreement StockIssuedDuringPeriodValueCommitmentFeeRelatedToEquityLineOfCreditAgreement		usd
	VERB	Stock Issued During The Conversion Of Class B Units To Common Shares StockIssuedDuringTheConversionOfClassBUnitsToCommonShares		usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease		usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets		usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts		usd
	VERB	Fair Value Of Derivative Liability Extinguished FairValueOfDerivativeLiabilityExtinguished		usd
	VERB	Fair Value Of Common Shares Issued To Settle Accounts Payable FairValueOfCommonSharesIssuedToSettleAccountsPayable		usd
	VERB	Reclassification Of Class B Upon Conversion To Common Stock ReclassificationOfClassBUponConversionToCommonStock		usd
	VERB	Fair Value Of Common Stock Issued To Settle Notes Payable Related Party FairValueOfCommonStockIssuedToSettleNotesPayableRelatedParty		usd
	VERB	Fair Value Of Common Stock Issued For Future Services FairValueOfCommonStockIssuedForFutureServices		usd
	VERB	Fair Value Of Debt Forgiveness FairValueOfDebtForgiveness		usd
	VERB	Fair Value Of Warrants Issued To Series Preferred Stockholders Deemed Dividend FairValueOfWarrantsIssuedToSeriesPreferredStockholdersDeemedDividend		usd
	VERB	Fair Value Of Common Stock Issued To Settle Lawsuit FairValueOfCommonStockIssuedToSettleLawsuit		usd
	VERB	Discount Recognized From Convertible Notes Payable DiscountRecognizedFromConvertibleNotesPayable		usd
	VERB	Derecognition Of Operating Lease Right Of Use Assets DerecognitionOfOperatingLeaseRightOfUseAssets		usd
	VERB	Derecognition Of Operating Lease Liabilities DerecognitionOfOperatingLeaseLiabilities		usd
	VERB	Recognition Of Operating Lease Rightofuse Asset And Related Lease Liability RecognitionOfOperatingLeaseRightofuseAssetAndRelatedLeaseLiability		usd
CY2020Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet		usd
CY2021	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1		usd
CY2021Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet		usd
CY2021Q4	VERB	Notes Payable Related Parties Debt Discount NotesPayableRelatedPartiesDebtDiscount		usd
CY2021Q4	VERB	Notes Payable Related Parties Debt Issuance Costs NotesPayableRelatedPartiesDebtIssuanceCosts		usd
CY2021Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts		usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts		usd
	VERB	Gain On Extinguishment Of Derivative Liability GainOnExtinguishmentOfDerivativeLiability		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures		shares
	VERB	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeited In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
	VERB	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Nonvested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-38834
	dei	Entity Registrant Name EntityRegistrantName	Verb Technology Company, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	90-1118043
	dei	Entity Address Address Line1 EntityAddressAddressLine1	3401 North Thanksgiving Way
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 240
	dei	Entity Address City Or Town EntityAddressCityOrTown	Lehi
	dei	Entity Address State Or Province EntityAddressStateOrProvince	UT
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	84043
	dei	City Area Code CityAreaCode	(855)
	dei	Local Phone Number LocalPhoneNumber	250-2300
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	116166300	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	921000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	937000	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1438000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1382000	usd
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	738000	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	875000	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	3097000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	3194000	usd
CY2022Q3	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	6444000	usd
CY2021Q4	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	4348000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	582000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	702000	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1624000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2177000	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2966000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3953000	usd
CY2022Q3	us-gaap	Goodwill Goodwill	19764000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	19764000	usd
CY2022Q3	us-gaap	Other Assets OtherAssets	306000	usd
CY2021Q4	us-gaap	Other Assets OtherAssets	293000	usd
CY2022Q3	us-gaap	Assets Assets	34783000	usd
CY2021Q4	us-gaap	Assets Assets	34431000	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3833000	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3751000	usd
CY2022Q3	us-gaap	Interest Payable Current InterestPayableCurrent	2096000	usd
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	3500000	usd
CY2022Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1274000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1209000	usd
CY2022Q3	VERB	Advances On Future Receipts Net AdvancesOnFutureReceiptsNet	2197000	usd
CY2021Q4	VERB	Advances On Future Receipts Net AdvancesOnFutureReceiptsNet	4181000	usd
CY2022Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	4171000	usd
CY2021Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	40000	usd
CY2021Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	521000	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	481000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	592000	usd
CY2022Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1549000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	986000	usd
CY2022Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	795000	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	3155000	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	16396000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	17935000	usd
CY2022Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	150000	usd
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	875000	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1705000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2299000	usd
CY2022Q3	us-gaap	Liabilities Liabilities	18251000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	21109000	usd
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	15000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	15000000	shares
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	102604851	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	102604851	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	72942948	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	72942948	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	10000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	7000	usd
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	10000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	7000	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	153940000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	129342000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-137418000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-116027000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	16532000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	13322000	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	34783000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	34431000	usd
CY2022Q3	VERB	Revenue From Contract With Customer Excluding Assessed Tax From Digital Revenue RevenueFromContractWithCustomerExcludingAssessedTaxFromDigitalRevenue	2016000	usd
CY2021Q3	VERB	Revenue From Contract With Customer Excluding Assessed Tax From Digital Revenue RevenueFromContractWithCustomerExcludingAssessedTaxFromDigitalRevenue	2356000	usd
	VERB	Revenue From Contract With Customer Excluding Assessed Tax From Digital Revenue RevenueFromContractWithCustomerExcludingAssessedTaxFromDigitalRevenue	6327000	usd
	VERB	Revenue From Contract With Customer Excluding Assessed Tax From Digital Revenue RevenueFromContractWithCustomerExcludingAssessedTaxFromDigitalRevenue	5967000	usd
CY2022Q3	VERB	Revenue From Contract With Customer Excluding Assessed Tax From Non Digital Revenue RevenueFromContractWithCustomerExcludingAssessedTaxFromNonDigitalRevenue	171000	usd
CY2021Q3	VERB	Revenue From Contract With Customer Excluding Assessed Tax From Non Digital Revenue RevenueFromContractWithCustomerExcludingAssessedTaxFromNonDigitalRevenue	544000	usd
	VERB	Revenue From Contract With Customer Excluding Assessed Tax From Non Digital Revenue RevenueFromContractWithCustomerExcludingAssessedTaxFromNonDigitalRevenue	950000	usd
	VERB	Revenue From Contract With Customer Excluding Assessed Tax From Non Digital Revenue RevenueFromContractWithCustomerExcludingAssessedTaxFromNonDigitalRevenue	1851000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2187000	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2900000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7277000	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	736000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7818000	usd
CY2021Q3	us-gaap	Cost Of Revenue CostOfRevenue	1086000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	2544000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	3420000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	1451000	usd
CY2021Q3	us-gaap	Gross Profit GrossProfit	1814000	usd
	us-gaap	Gross Profit GrossProfit	4733000	usd
	us-gaap	Gross Profit GrossProfit	4398000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1372000	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3513000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4334000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9610000	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	790000	usd
CY2021Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	400000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1594000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1214000	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6965000	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6130000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	20563000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	20018000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	9127000	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	10043000	usd
	us-gaap	Operating Expenses OperatingExpenses	26491000	usd
	us-gaap	Operating Expenses OperatingExpenses	30842000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-7676000	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-8229000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-21758000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-26444000	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	550000	usd
CY2021Q3	us-gaap	Interest Expense InterestExpense	525000	usd
	us-gaap	Interest Expense InterestExpense	1948000	usd
	us-gaap	Interest Expense InterestExpense	1629000	usd
CY2022Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	198000	usd
CY2021Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-141000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	2360000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-2086000	usd
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	8000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-45000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	85000	usd
CY2021Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	82000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1112000	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-352000	usd
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-576000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	367000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2518000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-8028000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-8805000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-21391000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-28962000	usd
CY2021Q3	us-gaap	Redeemable Preferred Stock Dividends RedeemablePreferredStockDividends	348000	usd
	us-gaap	Redeemable Preferred Stock Dividends RedeemablePreferredStockDividends	348000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8028000	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9153000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-21391000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-29310000	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.48
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	102110182	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	66760177	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	92040783	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60705062	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	13322000	usd
	us-gaap	Sale Of Stock Consideration Received Per Transaction SaleOfStockConsiderationReceivedPerTransaction	20150000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	377000	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	1461000	usd
	VERB	Stock Issued During The Fair Value Of Common Shares Issued To Settle Accrued Expenses StockIssuedDuringTheFairValueOfCommonSharesIssuedToSettleAccruedExpenses	450000	usd
	VERB	Stock Issued During The Fair Value Of Vested Restricted Stock Awards Stock Options And Warrants StockIssuedDuringTheFairValueOfVestedRestrictedStockAwardsStockOptionsAndWarrants	2163000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-21391000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	16532000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	23530000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	335000	usd
CY2022Q3	VERB	Stock Issued During The Fair Value Of Vested Restricted Stock Awards Stock Options And Warrants StockIssuedDuringTheFairValueOfVestedRestrictedStockAwardsStockOptionsAndWarrants	695000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-8028000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	16532000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	10745000	usd
	us-gaap	Sale Of Stock Consideration Received Per Transaction SaleOfStockConsiderationReceivedPerTransaction	18851000	usd
	VERB	Stock Issued During Period Value From Warrants Exercise StockIssuedDuringPeriodValueFromWarrantsExercise	2784000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	569000	usd
	VERB	Stock Issued During The Fair Value Of Common Shares Issued To Settle Note Payable Related Party StockIssuedDuringTheFairValueOfCommonSharesIssuedToSettleNotePayableRelatedParty	200000	usd
	VERB	Stock Issued During The Fair Value Of Common Shares Issued To Settle Lawsuit StockIssuedDuringTheFairValueOfCommonSharesIssuedToSettleLawsuit	678000	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	348000	usd
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	348000	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	1926000	usd
	VERB	Stock Issued During The Fair Value Of Common Shares Issued To Settle Accounts Payable StockIssuedDuringTheFairValueOfCommonSharesIssuedToSettleAccountsPayable	19000	usd
	VERB	Stock Issued During The Fair Value Of Vested Restricted Stock Awards StockIssuedDuringTheFairValueOfVestedRestrictedStockAwards	1285000	usd
	VERB	Stock Issued During The Fair Value Of Vested Stock Options And Warrants StockIssuedDuringTheFairValueOfVestedStockOptionsAndWarrants	1234000	usd
	VERB	Stock Issued During The Extinguishment Of Derivative Liability Upon Exercise Of Warrants StockIssuedDuringTheExtinguishmentOfDerivativeLiabilityUponExerciseOfWarrants	4513000	usd
	VERB	Stock Issued During The Fair Value Of Common Shares Issued To Settle Accrued Expenses StockIssuedDuringTheFairValueOfCommonSharesIssuedToSettleAccruedExpenses	281000	usd
	VERB	Stock Issued During The Fair Value Of Warrants Issued To Officer To Modify Note Payable StockIssuedDuringTheFairValueOfWarrantsIssuedToOfficerToModifyNotePayable	287000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	13487000	usd
CY2021Q3	us-gaap	Sale Of Stock Consideration Received Per Transaction SaleOfStockConsiderationReceivedPerTransaction	4722000	usd
CY2021Q3	VERB	Stock Issued During Period Value From Warrants Exercise StockIssuedDuringPeriodValueFromWarrantsExercise	1681000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	348000	usd
CY2021Q3	VERB	Fair Value Of Warrants Issued To Series Preferred Stockholders FairValueOfWarrantsIssuedToSeriesPreferredStockholders	-348000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-28962000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	14410000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	157000	usd
CY2021Q3	VERB	Stock Issued During The Fair Value Of Common Shares Issued To Settle Accounts Payable StockIssuedDuringTheFairValueOfCommonSharesIssuedToSettleAccountsPayable	19000	usd
CY2021Q3	VERB	Stock Issued During The Fair Value Of Vested Restricted Stock Awards StockIssuedDuringTheFairValueOfVestedRestrictedStockAwards	380000	usd
CY2021Q3	VERB	Stock Issued During The Fair Value Of Vested Stock Options And Warrants StockIssuedDuringTheFairValueOfVestedStockOptionsAndWarrants	364000	usd
CY2021Q3	VERB	Stock Issued During The Extinguishment Of Derivative Liability Upon Exercise Of Warrants StockIssuedDuringTheExtinguishmentOfDerivativeLiabilityUponExerciseOfWarrants	2213000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	192000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	192000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-8805000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	14410000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-21391000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-28962000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	3668000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	4652000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1214000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1537000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	390000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	2360000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-2086000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1112000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1594000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1214000	usd
	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	-22000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-10000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	6000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	405000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	151000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	461000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	721000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-146000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	301000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	222000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	424000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	13000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	790000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	910000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	563000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	631000	usd
	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	-377000	usd
	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	-521000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-397000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-493000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-15975000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-20511000	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	3000	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	11000	usd
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	4299000	usd
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	41000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	24000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	26000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	82000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4402000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-56000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	20150000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	18851000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	6000000	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	2500000	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	7368000	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	2784000	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	2740000	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	5381000	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	7162000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	377000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	569000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	545000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	20361000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	22410000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-16000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1843000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	937000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1815000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	921000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3658000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-21391000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-15975000	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	921000	usd
CY2021Q2	VERB	Employee Retention Credit Provisions EmployeeRetentionCreditProvisions	1500	usd
CY2021Q3	VERB	Employee Retention Credit Provisions EmployeeRetentionCreditProvisions	1500	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84B_eus-gaap--UseOfEstimates_z6RuDu5N7JF7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zXsfIlFDVoGe">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reported periods. Management bases these estimates and assumptions upon historical experience, existing and known circumstances, and other factors that management believes to be reasonable. In addition, the Company has considered the potential impact of the pandemic, as well as certain macroeconomic factors, including inflation, rising interest rates, and recessionary concerns, on its business and operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant estimates include assumptions made in analysis of reserves for allowance of doubtful accounts, inventory, assumptions made in purchase price allocations, impairment testing of long-term assets, realization of deferred tax assets, determining fair value of derivative liabilities, and valuation of equity instruments issued for services. Some of those assumptions can be subjective and complex, and therefore, actual results could differ materially from those estimates under different assumptions or conditions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Derivatives Reporting Of Derivative Activity DerivativesReportingOfDerivativeActivity	<p id="xdx_844_eus-gaap--DerivativesReportingOfDerivativeActivity_zK7caQjRBfqa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_zrWgQl5HTWa7">Derivative Financial Instruments</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the condensed consolidated statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the condensed consolidated balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company uses Level 2 inputs for its valuation methodology for the derivative liabilities as their fair values were determined by using a Binomial pricing model. The Company’s derivative liabilities are adjusted to reflect fair value at each period end, with any increase or decrease in the fair value being recorded in results of operations as adjusted to fair value of derivatives.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_zz1BuoPXeuTa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zZiebI83OJG3">Concentration of Credit and Other Risks</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash and accounts receivable. Cash is deposited with a limited number of financial institutions. The balances held at any one financial institution at times may be in excess of Federal Deposit Insurance Corporation (“FDIC”) insurance limits of up to $<span id="xdx_90E_eus-gaap--CashFDICInsuredAmount_iI_pn3n3_c20220930_zaesS491snCl" title="FDIC Insured Amount">250</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company evaluates the concentration of credit risk associated with key customers. During the three months ended September 30, 2022, we had one customer that accounted for <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220701__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zura9ZeU3272" title="Concentration risk, percentage">11</span>% of our revenues. During the three months ended September 30, 2021, we had no customers that accounted for <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210701__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_zX5ctL2Q1ML5" title="Concentration risk, percentage">10%</span> of our revenues. During the nine months ended September 30, 2022 and 2021, we had no customers that accounted for <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_z55W2XYAUN8c" title="Concentration risk, percentage"><span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_zu6nqKHAXiQf" title="Concentration risk, percentage">10</span></span>% of our revenues.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company extends limited credit to customers based on an evaluation of their financial condition and other factors. The Company generally does not require collateral or other security to support accounts receivable. The Company performs ongoing credit evaluations of its customers and maintains an allowance for doubtful accounts and sales credits. The Company believes that any concentration of credit risk in its accounts receivable is substantially mitigated by the Company’s evaluation process, relatively short collection terms and credit worthiness of its customers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of September 30, 2022 and December 31, 2021, we had no customers that accounted for <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220930__srt--MajorCustomersAxis__custom--NoCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zQImfI5JTNag" title="Concentration risk, percentage"><span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__srt--MajorCustomersAxis__custom--NoCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z2fM4PlKnfy6" title="Concentration risk, percentage">10</span></span>% of our accounts receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company also evaluates the concentration of risk associated with key vendors. For the three and nine months ended September 30, 2022, we had two vendors that accounted for <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220701__20220930__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zF2unjh47sXa" title="Concentration risk, percentage">54</span>% and <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_z0F4lBQrQili" title="Concentration risk, percentage">45</span>% and <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220701__20220930__srt--MajorCustomersAxis__custom--VendorTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zcC9OrtT1fYj" title="Concentration risk, percentage">11</span>% and <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__srt--MajorCustomersAxis__custom--VendorTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_z6m5F2900Ct2" title="Concentration risk, percentage">16</span>%, respectively, of our purchases individually and <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20220701__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoVendorsMember_zTcWEQey9W82" title="Concentration risk, percentage">65</span>% and <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoVendorsMember_zqqGWAZ49D6c" title="Concentration risk, percentage">61</span>% in the aggregate. For the three and nine months ended September 30, 2021, we had two vendors that accounted for <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210701__20210930__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zDtj5U138WG7" title="Concentration risk, percentage">17</span>% and <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20210930__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_ziAyHIbysWel" title="Concentration risk, percentage">31</span>% and <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210701__20210930__srt--MajorCustomersAxis__custom--VendorTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zG4LU1FisAQe" title="Concentration risk, percentage">16</span>% and <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20210930__srt--MajorCustomersAxis__custom--VendorTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zOvPit6SUyD6" title="Concentration risk, percentage">20</span>%, respectively, of our purchases individually and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoVendorsMember_z83m79v9w4ld" title="Concentration risk, percentage">48</span>% and <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoVendorsMember_zp1zyHlRzjSc" title="Concentration risk, percentage">36</span>% in the aggregate. As of September 30, 2022 and December 31, 2021, we had one vendor that accounted for <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__srt--MajorCustomersAxis__custom--OneVendorMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zHxdlaepsmOc" title="Concentration risk, percentage">42</span>% and <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__srt--MajorCustomersAxis__custom--OneVendorMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zES8OBIuTj56" title="Concentration risk, percentage">40</span>%, respectively, of accounts payable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_847_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zO7YETktK7I1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_zuBfAVf86P04">Reclassification Adjustment</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company reclassified $<span id="xdx_907_ecustom--ReclassificationOfCash_pn3n3_c20220101__20220930_zi57JZGgFOxl" title="Reclassification of cash">2,288</span> from net cash used in investing activities to net cash used in operating activities for the nine months ended September 30, 2021. This amount is now reported as accrued software development costs in the supplemental non-cash investing and financing activities as part of the supplemental cash flow information.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_zUhfr5PnvtF7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Supplemental Cash Flow Information</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span id="xdx_8B9_zeOxeMPypBRh" style="display: none">SCHEDULE OF SUPPLEMENTAL CASH FLOW INFORMATION</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20220101__20220930_zgJOv822ixp" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20210101__20210930_zJQFo5JU99f3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nine Months Ended September 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_408_eus-gaap--SupplementalCashFlowInformationAbstract_iB_zwuEYEOxQ3Z5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Supplemental disclosures of cash flow information:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--InterestPaidNet_pn3n3_zhtzfmSZoTC8" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 60%; text-align: left">Cash paid for interest</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">203</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">112</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--IncomeTaxesPaidNet_iN_pn3n3_di_zrMq9kzLgjv4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Cash paid for income taxes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_iB_zDScoeSjbt9f" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Supplemental disclosure of non-cash investing and financing activities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_ecustom--FairValueOfDerivativeLiabilityExtinguished_pn3n3_zmzCFDP36A35" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Fair value of derivative liability extinguished</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1148">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,513</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_ecustom--FairValueOfCommonSharesIssuedToSettleAccountsPayable_zV2uTY2FmRbh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Fair value of common shares issued to settle accounts payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1151">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">19</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_ecustom--FairValueOfCommonSharesIssuedToSettleAccruedExpenses_pn3n3_zdwFT4rfqBNk" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Fair value of common shares issued to settle accrued expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">450</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">281</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--ReclassificationOfClassBUponConversionToCommonStock_zVRspBdje9r3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Reclassification of Class B Units upon conversion to common stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1157">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,065</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_ecustom--FairValueOfCommonStockIssuedToSettleNotesPayableRelatedParty_ze0rLnxXGYX" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Fair value of common stock issued to settle notes payable – related party</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1160">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">200</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--FairValueOfCommonStockReceivedInExchangeForEmployeesPayrollTaxes_zgkdyZrSIDb5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Fair value of common stock received in exchange for employee’s payroll taxes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">130</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_ecustom--FairValueOfCommonStockIssuedForFutureServices_zU2xUJQfAIr8" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Fair value of common stock issued for future services</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1166">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">164</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_ecustom--DiscountRecognizedFromAdvancesOnFutureReceipts_zJi0e6eAXTKf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Discount recognized from advances on future receipts</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">900</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,484</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--FairValueOfDebtForgiveness_zftoCkBqfrp" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Fair value of debt forgiveness</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1172">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,400</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_ecustom--FairValueOfWarrantsIssuedToSeriesPreferredStockholdersDeemedDividend_zn1VIMfUnDD1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Fair value of warrants issued to Series A preferred stockholders – deemed dividend</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1175">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">348</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_ecustom--FairValueOfCommonStockIssuedToSettleLawsuit_zXykjdsHcTH5" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Fair value of common stock issued to settle lawsuit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1178">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">678</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--AccruedSoftwareDevelopmentCosts_zIirwJuhxzLc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Accrued software development costs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">291</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,288</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_ecustom--DiscountRecognizedFromConvertibleNotesPayable_pn3n3_zDzdMHrQGu3a" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Discount recognized from convertible notes payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">300</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1185">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--DerecognitionOfOperatingLeaseRightOfUseAssets_pn3n3_zyEo0pZaJjV" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Derecognition of operating lease right-of-use assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">543</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1188">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--DerecognitionOfOperatingLeaseLiabilities_pn3n3_zfAlvwxgIWNd" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Derecognition of operating lease liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">521</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1191">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_405_ecustom--RecognitionOfOperatingLeaseRightofuseAssetAndRelatedLeaseLiability_pn3n3_zvECHJofuT6i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Recognition of operating lease right-of-use asset and related lease liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">212</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1194">-</span></td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A3_zTBH28VRcaPd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	VERB	Reclassification Of Cash ReclassificationOfCash	2288000	usd
	us-gaap	Interest Paid Net InterestPaidNet	203000	usd
	us-gaap	Interest Paid Net InterestPaidNet	112000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-1000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-1000	usd
	VERB	Fair Value Of Derivative Liability Extinguished FairValueOfDerivativeLiabilityExtinguished	4513000	usd
	VERB	Fair Value Of Common Shares Issued To Settle Accounts Payable FairValueOfCommonSharesIssuedToSettleAccountsPayable	19000	usd
	VERB	Fair Value Of Common Shares Issued To Settle Accrued Expenses FairValueOfCommonSharesIssuedToSettleAccruedExpenses	450000	usd
	VERB	Fair Value Of Common Shares Issued To Settle Accrued Expenses FairValueOfCommonSharesIssuedToSettleAccruedExpenses	281000	usd
	VERB	Reclassification Of Class B Upon Conversion To Common Stock ReclassificationOfClassBUponConversionToCommonStock	3065000	usd
	VERB	Fair Value Of Common Stock Issued To Settle Notes Payable Related Party FairValueOfCommonStockIssuedToSettleNotesPayableRelatedParty	200000	usd
	VERB	Fair Value Of Common Stock Received In Exchange For Employees Payroll Taxes FairValueOfCommonStockReceivedInExchangeForEmployeesPayrollTaxes	8000	usd
	VERB	Fair Value Of Common Stock Received In Exchange For Employees Payroll Taxes FairValueOfCommonStockReceivedInExchangeForEmployeesPayrollTaxes	130000	usd
	VERB	Fair Value Of Common Stock Issued For Future Services FairValueOfCommonStockIssuedForFutureServices	164000	usd
	VERB	Discount Recognized From Advances On Future Receipts DiscountRecognizedFromAdvancesOnFutureReceipts	900000	usd
	VERB	Discount Recognized From Advances On Future Receipts DiscountRecognizedFromAdvancesOnFutureReceipts	2484000	usd
	VERB	Fair Value Of Debt Forgiveness FairValueOfDebtForgiveness	1400000	usd
	VERB	Fair Value Of Warrants Issued To Series Preferred Stockholders Deemed Dividend FairValueOfWarrantsIssuedToSeriesPreferredStockholdersDeemedDividend	348000	usd
	VERB	Fair Value Of Common Stock Issued To Settle Lawsuit FairValueOfCommonStockIssuedToSettleLawsuit	678000	usd
	VERB	Accrued Software Development Costs AccruedSoftwareDevelopmentCosts	291000	usd
	VERB	Accrued Software Development Costs AccruedSoftwareDevelopmentCosts	2288000	usd
	VERB	Discount Recognized From Convertible Notes Payable DiscountRecognizedFromConvertibleNotesPayable	300000	usd
	VERB	Derecognition Of Operating Lease Right Of Use Assets DerecognitionOfOperatingLeaseRightOfUseAssets	543000	usd
	VERB	Derecognition Of Operating Lease Liabilities DerecognitionOfOperatingLeaseLiabilities	521000	usd
	VERB	Recognition Of Operating Lease Rightofuse Asset And Related Lease Liability RecognitionOfOperatingLeaseRightofuseAssetAndRelatedLeaseLiability	212000	usd
CY2022Q3	VERB	Accrued Other Capitalized Software Development Costs AccruedOtherCapitalizedSoftwareDevelopmentCosts	524000	usd
CY2021Q4	VERB	Accrued Other Capitalized Software Development Costs AccruedOtherCapitalizedSoftwareDevelopmentCosts	248000	usd
CY2021Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	4348000	usd
	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	2490000	usd
CY2021	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	4348000	usd
	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	394000	usd
CY2022Q3	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	6444000	usd
CY2021Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	4348000	usd
CY2021Q3	VERB	Break Up Fee Payable BreakUpFeePayable	1000000	usd
CY2021Q3	VERB	Business Combination Consideration Transferred Assumption Description BusinessCombinationConsiderationTransferredAssumptionDescription	the purchase price for the Primary Contractor would be $12,000, which can be paid in cash and/or stock, although the final terms of the acquisition will be set forth in the SPA.
CY2022Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	7399000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	7317000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4875000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3806000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2524000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3511000	usd
CY2022Q3	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	442000	usd
CY2021Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	442000	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2966000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3953000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	352000	usd
CY2021Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	355000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1069000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1080000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	354000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1386000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	573000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	211000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2524000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	373000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	524000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	458000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	593000	usd
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y11M26D
CY2021Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y1M24D
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.042	pure
CY2021Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.040	pure
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1624000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2177000	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	481000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	592000	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1705000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2299000	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	2186000	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2891000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	150000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	583000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	472000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	484000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	705000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2394000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	208000	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	2186000	usd
	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	10017000	usd
CY2022Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	2971000	usd
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	4981000	usd
CY2022Q3	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	697000	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	800000	usd
CY2022Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	77000	usd
CY2022Q3	VERB	Advances On Future Receipts Net AdvancesOnFutureReceiptsNet	2197000	usd
CY2021Q4	VERB	Advances On Future Receipts Net AdvancesOnFutureReceiptsNet	4181000	usd
CY2022Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	2971000	usd
CY2022Q3	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	697000	usd
CY2022Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	77000	usd
CY2022Q3	VERB	Notes Payable Related Parties Debt Discount NotesPayableRelatedPartiesDebtDiscount	-61000	usd
CY2022Q3	VERB	Notes Payable Related Parties Debt Issuance Costs NotesPayableRelatedPartiesDebtIssuanceCosts	-93000	usd
CY2022Q3	us-gaap	Notes Payable NotesPayable	4321000	usd
CY2021Q4	us-gaap	Notes Payable NotesPayable	915000	usd
CY2022Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	150000	usd
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	875000	usd
CY2022Q3	us-gaap	Notes Payable Current NotesPayableCurrent	4171000	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	40000	usd
CY2022Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	306000	usd
CY2021Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	497000	usd
CY2022Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	126000	usd
CY2022Q3	us-gaap	Interest Expense Other InterestExpenseOther	118000	usd
CY2021Q3	us-gaap	Interest Expense Other InterestExpenseOther	28000	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	550000	usd
CY2021Q3	us-gaap	Interest Expense InterestExpense	525000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1214000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1537000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	390000	usd
	us-gaap	Interest Expense Other InterestExpenseOther	344000	usd
	us-gaap	Interest Expense Other InterestExpenseOther	92000	usd
	us-gaap	Interest Expense InterestExpense	1948000	usd
	us-gaap	Interest Expense InterestExpense	1629000	usd
CY2022Q3	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	795000	usd
CY2021Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	3155000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	2360000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-2086000	usd
CY2021Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	4513000	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	3155000	usd
CY2020Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	8266000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	2360000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-2086000	usd
	VERB	Gain On Extinguishment Of Derivative Liability GainOnExtinguishmentOfDerivativeLiability	-4513000	usd
CY2022Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	795000	usd
CY2021Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	5839000	usd
	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	587347	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1821833	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	1.41
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	1334270	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.17
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	587347	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	1.54
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	496907000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	1.33
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	2071849	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	1.24
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5404223	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.72
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y2M26D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	107000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	2741555	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.06
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	2560929	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.70
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	332730	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.13
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5252119	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.55
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	19000	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	2707084	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	1.81
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	1686439	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	2.22
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	19000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0124	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0337	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0010	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0092	pure
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	1.436	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	1.495	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	2.328	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	2.400	pure
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	10984740	shares
CY2021Q4	VERB	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice	2.67
	VERB	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms Beginning ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTermsBeginning	P2Y4M17D
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Nonvested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested	507000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	14666667	shares
	VERB	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice	0.75
	VERB	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTermsGranted	P5Y25D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	25651407	shares
CY2022Q3	VERB	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice	1.52
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P3Y6M7D
	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	300000	usd
CY2021Q4	us-gaap	Legal Fees LegalFees	915000	usd

Files In Submission

Name	View Source	Status
0001493152-22-032056-index-headers.html	Edgar Link	pending
0001493152-22-032056-index.html	Edgar Link	pending
0001493152-22-032056.txt	Edgar Link	pending
0001493152-22-032056-xbrl.zip	Edgar Link	pending
ex10-1.htm	Edgar Link	pending
ex10-2.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
verb-20220930.xsd	Edgar Link	pending
verb-20220930_cal.xml	Edgar Link	unprocessable
verb-20220930_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
verb-20220930_def.xml	Edgar Link	unprocessable
verb-20220930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VERB
Verb Technology Company, Inc. Stock $verb

2022 Q4 Form 10-Q Financial Statement

#000149315222032056 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VERB Verb Technology Company, Inc. Stock $verb

2022 Q4 Form 10-Q Financial Statement

#000149315222032056 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VERB
Verb Technology Company, Inc. Stock $verb